Carregant...
3.2 Can Neurobiological Subgroups in Psychotic Illness Advantage Drug DISCOVERY?
Background: Are there neurobiological subgroups in schizophrenia or across psychotic illnesses that will select individuals who will respond to drugs that enhance parvalbumin (PV)-positive inhibitory interneuron function? The question requires not only clarification and validation of biomarker-based...
Guardat en:
| Publicat a: | Schizophr Bull |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475469/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx021.008 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|